Sernova Corp. – TSX:SVA.TO

Sernova Corp. stock price today

CAD 0.88
+0.65
+291.11%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sernova Corp. stock price monthly change

-26.23%
month

Sernova Corp. stock price quarterly change

-26.23%
quarter

Sernova Corp. stock price yearly change

-65.91%
year

Sernova Corp. key metrics

Market Cap
 71.57M
Enterprise value
 244.68M
P/E
 -9.78
EV/Sales
 N/A
EV/EBITDA
 -9.26
Price/Sales
 N/A
Price/Book
 6.58
PEG ratio
 0.04
EPS
 -0.13
Revenue
 N/A
EBITDA
 -40.95M
Income
 -41.32M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sernova Corp. stock price history

Sernova Corp. stock forecast

Sernova Corp. financial statements

Profit Margin

Sernova Corp. (TSX:SVA.TO): Profit margin
Jul 2023 0 -9.93M
Oct 2023 0 -11.70M
Jan 2024 0 -9.74M
Apr 2024 0 -9.94M
SVA.TO income statement history

Sernova Corp. Financials Estimate

Sernova Corp. (TSX:SVA.TO): Analyst Estimates
Jan 2024 0 -9.74M
Apr 2024 0 -9.94M
Oct 2025 0 -9.10M
Oct 2025 0 -9.09M

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Quarterly Earnings

Sernova Corp. (TSX:SVA.TO): Earnings per share (EPS)
2024-09-16 -0.015 -0.02
2024-12-23 -0.02 -0.01
SVA.TO earnings history

Debt to Assets

Sernova Corp. (TSX:SVA.TO): Debt to assets
Jul 2023 33203107 9.93M 29.92%
Oct 2023 22106815 9.59M 43.39%
Jan 2024 18572529 14.73M 79.36%
Apr 2024 11765522 17.26M 146.78%
SVA.TO balance sheet history

Cash Flow

Sernova Corp. (TSX:SVA.TO): Cash Flow
Jul 2023 -4.47M 9.61M -42.84K
Oct 2023 -11.35M 2.17M 118.85K
Jan 2024 -4.24M 2.07M -43.14K
Apr 2024 -7.23M 4M 166.75K
SVA.TO cash flow history

Sernova Corp. alternative data

Sernova Corp.
Employees

Sernova Corp. (TSX:SVA.TO): Employee count
Mar 2024 26
Apr 2024 26
May 2024 26
Jun 2024 26
Jul 2024 26

Sernova Corp. other data

Frequently Asked Questions (FAQ)

  • What's the price of Sernova Corp. stock today?

    One share of Sernova Corp. stock can currently be purchased for approximately $0.88.

  • When is Sernova Corp.'s next earnings date?

    Sernova Corp. is estimated to report earnings on Monday, 15 Sep 2025.

  • Does Sernova Corp. pay dividends?

    No, Sernova Corp. does not pay dividends.

  • How much money does Sernova Corp. make?

    Sernova Corp. has a market capitalization of 71.57M. Sernova Corp. made a loss 39M US dollars in net income (profit) last year or -$0.01 on an earnings per share basis.

  • What is Sernova Corp.'s stock symbol?

    Sernova Corp. is traded on the TSX under the ticker symbol "SVA.TO".

  • What is Sernova Corp.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Sernova Corp.?

    Shares of Sernova Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Sernova Corp. have?

    As Jul 2024, Sernova Corp. employs 26 workers.

  • When Sernova Corp. went public?

    Sernova Corp. is publicly traded company for more then 26 years since IPO on 29 Apr 1999.

  • What is Sernova Corp.'s official website?

    The official website for Sernova Corp. is sernova.com.

  • Where are Sernova Corp.'s headquarters?

    Sernova Corp. is headquartered at The Stiller Centre, London, ON.

  • How can i contact Sernova Corp.?

    Sernova Corp.'s mailing address is The Stiller Centre, London, ON and company can be reached via phone at +51 98585184.

Sernova Corp. company profile:

Sernova Corp.

sernova.com
Exchange:

TSX

Full time employees:

26

Industry:

Biotechnology

Sector:

Healthcare

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.

+51 98585184
The Stiller Centre
London, ON N6G 4X8

:
ISIN: CA81732W1041
: